Display options
Share it on

S Afr J Infect Dis. 2021 Mar 05;36(1):215. doi: 10.4102/sajid.v36i1.215. eCollection 2021.

Immunotherapy of COVID-19 with Bacille Calmette - Guerin: Where is the missing red herring?.

Southern African journal of infectious diseases

Hari M Saxena

Affiliations

  1. Department of Veterinary Microbiology, Guru Angad Dev Veterinary and Animal Sciences University, Ludhiana, India.

PMID: 34485493 PMCID: PMC8378185 DOI: 10.4102/sajid.v36i1.215

Abstract

Coronavirus Disease 2019 (COVID-19) morbidity and mortality was found to be less severe in countries where Bacille Calmette - Guerin (BCG) vaccination of the population is carried out. Conjugating Purified Protein Derivative (PPD) onto tumour cells and injecting into BCG primed mice was found to enhance anti-tumour immune response. We had proposed earlier that

© 2021. The Authors.

Keywords: BCG; COVID 19; PPD; SARS CoV2; coronavirus; immunotherapy; vaccine

Conflict of interest statement

The author declares that he has no financial or personal relationships that may have inappropriately influenced him in writing this opinion paper.

References

  1. Immunology. 2002 May;106(1):96-101 - PubMed
  2. Immunology. 1984 Dec;53(4):601-10 - PubMed
  3. Tuberculosis (Edinb). 2009 Nov;89(6):423-30 - PubMed
  4. Proteomics. 2012 Apr;12(7):979-91 - PubMed
  5. Respir Res. 2020 Jul 11;21(1):178 - PubMed
  6. Nature. 1978 Feb 2;271(5644):463-4 - PubMed
  7. Med Hypotheses. 1989 Aug;29(4):255-9 - PubMed
  8. Proc Natl Acad Sci U S A. 2020 Jul 28;117(30):17720-17726 - PubMed

Publication Types